Divine

Divine is an AI-driven biotechnology company focused on revolutionizing drug discovery by targeting previously "undruggable" proteins. The company utilizes a proprietary platform that combines advanced machine learning algorithms with high-throughput experimental validation to identify novel binding pockets and small molecule candidates. By integrating computational structural biology with deep learning, Divine aims to accelerate the development of therapies for complex diseases in oncology and neurodegeneration. Their approach focuses on high-value targets where traditional screening methods have historically failed, positioning them as a leader in the next generation of precision medicine.